Literature DB >> 15170446

Exploiting tumour hypoxia in cancer treatment.

J Martin Brown1, William R Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15170446     DOI： 10.1038/nrc1367

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  715 in total

1.  Escherichia coli succinic thiolinase. Stoichiometry of phosphorylation and coenzyme A binding.

Authors:  C M Bowman; J S Nishimura
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

2.  Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?

Authors:  Glen Kristiansen; Junmin Hu; Daniela Wichmann; Daniel P Stiehl; Michael Rose; Josefine Gerhardt; Annette Bohnert; Anette ten Haaf; Holger Moch; James Raleigh; Mahesh A Varia; Patrick Subarsky; Francesca M Scandurra; Erich Gnaiger; Eva Gleixner; Anne Bicker; Max Gassmann; Thomas Hankeln; Edgar Dahl; Thomas A Gorr
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

3.  Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia.

Authors:  Zhiyong Poon; Dongsook Chang; Xiaoyong Zhao; Paula T Hammond
Journal:  ACS Nano       Date:  2011-04-29       Impact factor: 15.881

4.  Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.

Authors:  Nilesh K Wagh; Zhengyuan Zhou; Sunny M Ogbomo; Wen Shi; Susan K Brusnahan; Jered C Garrison
Journal:  Bioconjug Chem       Date:  2012-02-16       Impact factor: 4.774

5.  Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.

Authors:  Vincent Crenn; Kevin Biteau; Jérôme Amiaud; Clotilde Dumars; Romain Guiho; Luciano Vidal; Louis-Romée Le Nail; Dominique Heymann; Anne Moreau; François Gouin; Françoise Redini
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 6.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

Review 7.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 8.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response.

Authors:  S R McKeown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

Review 9.  Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.

Authors:  Sarah Crawford
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

Review 10.  Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment.

Authors:  Yu Shao; Wenzhe Huang; Changying Shi; Sean T Atkinson; Juntao Luo
Journal:  Ther Deliv       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.